First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...
The US recalled ReBoost Nasal Spray due to potential life-threatening infections caused by microbial contamination. While no ...
MediNatura New Mexico Inc. has issued a voluntary nationwide recall of its ReBoost Nasal Spray due to potential mold ...
The project, funded by the inaugural Trinity-SwRI Research Collaboration Program, is developing a formulation for intranasal ...
MedPage Today on MSN
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
8don MSN
Study finds saline nasal care reduces upper respiratory infections in children: Here’s how it works
A simple saltwater nasal rinse can significantly shorten children's colds by up to two days, according to a major study. This ...
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review. The Medicines and Healthcare ...
Investing.com -- Milestone Pharmaceuticals (NASDAQ:MIST) stock surged 35% after the company received FDA approval for CARDAMYST, the first self-administered nasal spray for adults with paroxysmal ...
Morning Overview on MSN
An experimental nasal spray could fight lethal brain cancer
Glioblastoma is one of the most lethal brain cancers known, and for decades treatment has barely budged survival curves despite surgery, radiation, and chemotherapy. Now researchers are testing a ...
InvestorsHub on MSN
Milestone Pharmaceuticals shares rally after FDA greenlights first at-home PSVT nasal therapy
Milestone Pharmaceuticals (NASDAQ:MIST) shares jumped roughly 35% after the U.S. Food and Drug Administration approved ...
Flu activity in Massachusetts has officially reached high levels, and doctors at pediatric emergency departments are seeing a ...
"People are looking for wellness tools that work with their bodies, not against them," said Morley Baker, CEO of Shed. "With microdose GLP-1, NAD+, and Glutathione, we're giving our community ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results